Explore 3 Stock Ideas & Industry Insights Download Free Report

BWX Technologies Inc

Industrials US BWXT

184.72USD
-2.54(1.36%)

Last update at 2026-06-03T20:28:00Z

Day Range

182.50187.47
LowHigh

52 Week Range

101.75241.82
LowHigh

Fundamentals

  • Previous Close 187.26
  • Market Cap20909.50M
  • Volume1270652
  • P/E Ratio63.75
  • Dividend Yield0.42%
  • EBITDA447.50M
  • Revenue TTM3198.43M
  • Revenue Per Share TTM34.93
  • Gross Profit TTM 732.86M
  • Diluted EPS TTM3.58

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 398.12M 348.72M 321.40M 314.38M 395.71M
Minority interest -0.91600M -0.35700M -0.11100M -0.42900M 0.42M
Net income 329.86M 281.94M 245.85M 238.19M 305.87M
Selling general administrative 394.42M 318.66M 266.41M 234.28M 230.40M
Selling and marketing expenses - - - - -
Gross profit 731.52M 655.21M 620.59M 551.93M 550.28M
Reconciled depreciation 109.19M 85.86M 77.24M 73.84M 69.08M
Ebit 442.33M 388.19M 368.44M 348.57M 345.85M
Ebitda 551.51M 474.06M 447.00M 430.15M 497.02M
Depreciation and amortization 109.19M 85.86M 78.57M 81.58M 151.17M
Non operating income net other - - - -34.19400M 49.87M
Operating income 323.24M 380.61M 383.06M 348.57M 345.85M
Other operating expenses 2875.13M 2323.05M 2113.25M 1924.72M 1815.26M
Interest expense 44.21M 39.48M 47.04M 36.41M 35.76M
Tax provision 68.26M 66.42M 69.55M 75.76M 89.42M
Interest income 3.89M 2.55M 1.92M 0.76M 0.42M
Net interest income -40.31400M -36.92100M -44.70900M -35.65200M -35.34200M
Extraordinary items - - - - -
Non recurring - - - 5.52M -3.53200M
Other items - - - - -
Income tax expense 68.26M 66.42M 75.08M 75.76M 89.42M
Total revenue 3198.43M 2703.65M 2496.31M 2232.83M 2124.07M
Total operating expenses 408.28M 274.60M 237.53M 243.82M 241.46M
Cost of revenue 2466.85M 2048.45M 1875.72M 1680.90M 1573.80M
Total other income expense net 74.88M -31.88700M -61.65900M -34.19400M 49.87M
Discontinued operations - - - - -
Net income from continuing ops 329.86M 282.30M 223.04M 238.62M 306.29M
Net income applicable to common shares - - - 238.19M 305.87M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 4271.49M 2869.92M 2747.07M 2618.94M 2501.38M
Intangible assets 329.86M 165.32M 185.51M 193.61M 185.55M
Earning assets - - - - -
Other current assets 112.61M 51.87M 36.92M 55.04M 47.72M
Total liab 3038.48M 1789.52M 1813.76M 1870.58M 1864.14M
Total stockholder equity 1233.01M 1080.68M 933.35M 748.31M 637.17M
Deferred long term liab - - - - -
Other current liab 521.93M 142.33M 130.75M 145.77M 158.15M
Common stock 1.29M 1.28M 1.28M 1.28M 1.27M
Capital stock 1.29M 1.28M 1.28M 1.28M 1.27M
Retained earnings 2523.63M 2287.15M 2093.92M 1932.97M 1775.75M
Other liab - - - 202.09M 204.08M
Good will 500.86M 287.36M 297.02M 293.17M 285.50M
Other assets - - - 67.75M 69.71M
Cash 502.86M 74.11M 78.62M 35.24M 33.89M
Cash and equivalents - - - - -
Total current liabilities 672.02M 474.20M 375.05M 367.86M 459.62M
Current deferred revenue - 161.29M 107.39M 88.73M 111.62M
Net debt 1513.12M 981.36M 1151.28M 1253.63M 1155.41M
Short term debt 8.80M 12.50M 10.25M 6.25M -
Short long term debt - 12.50M 6.25M 6.25M -
Short long term debt total 2015.98M 1055.47M 1229.91M 1288.87M 1189.30M
Other stockholder equity -1273.05900M -1159.54300M -1154.38400M -1164.00700M -1151.99200M
Property plant equipment - - - 1134.90M 1045.64M
Total current assets 1560.35M 930.00M 817.80M 771.62M 773.73M
Long term investments 158.39M 110.01M 98.10M 108.30M 85.28M
Net tangible assets - - - 261.53M 166.12M
Short term investments - -3.67700M 2.99M 3.80M 3.81M
Net receivables 944.88M 763.72M 674.86M 674.61M 685.42M
Long term debt 2015.98M 1042.97M 1203.42M 1282.62M 1189.30M
Inventory 46.54M 40.30M 27.40M 2.93M 2.90M
Accounts payable 141.29M 158.08M 126.65M 127.11M 189.84M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 0.04M 0.06M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -19.37300M -48.21100M -7.46300M -21.93000M 12.14M
Additional paid in capital - - - - -
Common stock total equity - - - 1.28M 1.27M
Preferred stock total equity - - - - -
Retained earnings total equity - - - 1932.97M 1775.75M
Treasury stock - - - - -1326.28000M
Accumulated amortization - - - - -
Non currrent assets other 1717.70M 92.50M 57.28M 96.77M 94.72M
Deferred long term asset charges - - - - -
Non current assets total 2711.14M 1939.93M 1929.26M 1847.32M 1727.65M
Capital lease obligations - - - - -
Long term debt total - - - 1282.62M 1189.30M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 3.40M -154.56100M -168.14500M -256.23600M 0.81M
Change to liabilities - - - -60.20700M 30.92M
Total cashflows from investing activities -742.10900M -154.56100M - -256.23600M -304.65300M
Net borrowings 987.50M -156.25000M - 97.59M 220.72M
Total cash from financing activities 693.64M -252.78500M -169.37100M 13.95M -90.13600M
Change to operating activities - - - -76.79500M -64.52100M
Net income 329.86M 282.30M 245.85M 238.62M 306.29M
Change in cash 426.63M -1.04400M 40.62M 1.22M -8.52300M
Begin period cash flow 80.57M 81.61M 40.99M 39.77M 48.30M
End period cash flow 507.20M 80.57M 81.61M 40.99M 39.77M
Total cash from operating activities 479.85M 408.43M 363.70M 244.70M 386.03M
Issuance of capital stock - - - - -
Depreciation 109.19M 85.86M 78.57M 73.84M 69.08M
Other cashflows from investing activities -22.40500M -0.91400M - -57.93400M 5.58M
Dividends paid 92.47M 88.35M -84.97400M 81.07M 79.67M
Change to inventory - - - - -1.99100M
Change to account receivables -93.26600M -26.05700M 0.46M 19.36M 87.88M
Sale purchase of stock -30.00000M -20.00000M -7.59200M -26.58800M -230.82800M
Other cashflows from financing activities 7.60M 11.81M 4.45M 999.81M -7.22700M
Change to netincome - - - 23.83M 47.08M
Capital expenditures 184.56M 153.65M 151.29M 198.31M 311.05M
Change receivables - - - 15.17M 84.01M
Cash flows other operating - - - -46.59400M -155.56200M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - 2.42M -8.76300M
Change in working capital -29.49900M -9.11300M -16.67500M -141.50200M -14.74100M
Stock based compensation 26.07M 21.68M 15.90M 14.13M 18.61M
Other non cash items -5.18900M 7.86M 45.19M 54.10M -33.30500M
Free cash flow 295.29M 254.78M 212.41M 46.39M 74.97M

Peer Comparison

Sector: Industrials Industry: Aerospace & Defense

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BWXT
BWX Technologies Inc
-2.54 1.36% 184.72 63.75 51.81 6.54 16.96 7.01 40.66
GE
GE Aerospace
-3.08 0.97% 314.64 35.57 40.82 6.53 16.98 7.09 26.97
BA
The Boeing Company
-7.12 3.27% 210.58 88.37 153.85 1.93 31.61 2.21 26.81
EADSY
Airbus Group NV
-1.24 2.48% 48.80 26.90 24.39 2.26 5.35 1.79 12.83
EADSF
Airbus Group SE
-2.0 0.99% 199.00 25.86 24.21 2.15 5.30 1.79 12.83

Reports Covered

Stock Research & News

Profile

BWX Technologies, Inc. manufactures and sells nuclear components in the United States, Canada, and internationally. The company operates through two segments, Government Operations and Commercial Operations. It manufactures precision naval nuclear components, reactors, and nuclear fuel; close-tolerance and high-quality equipment for nuclear applications; critical nuclear components, fuels and assemblies for government and limited other uses; down blend government stockpiles of uranium; and fabricate fuel-bearing precision components. The company also supplies proprietary and sole-source valves, manifolds, and fittings to naval and commercial shipping customers; research reactor fuel elements for colleges, universities, and national laboratories; and components for defense applications. In addition, it manufactures commercial nuclear steam generators, nuclear fuel, fuel handling systems, pressure vessels, reactor components, heat exchangers, tooling delivery systems; and containers for the storage of nuclear fuel and other high-level nuclear waste. Further, the company supplies nuclear fuel, fuel handling systems, tooling delivery systems, nuclear-grade materials and precisely machined components; and manufactures medical radioisotopes, radiopharmaceuticals, and medical devices. Additionally, it provides specialized engineering services that include structural component design, 3-D thermal-hydraulic engineering analysis, weld and robotic process development, electrical and controls engineering and metallurgy and materials engineering; in-plant inspection, maintenance and modification services; and non-destructive examination and tooling/repair solutions. It also offers nuclear power plant lifecycle support and management services. The company was formerly known as The Babcock & Wilcox Company and changed its name to BWX Technologies, Inc. in June 2015. BWX Technologies, Inc. was founded in 1867 and is headquartered in Lynchburg, Virginia.

BWX Technologies Inc

800 Main Street, Lynchburg, VA, United States, 24504

Key Executives

Name Title Year Born
Mr. Rex D. Geveden Pres, CEO & Director 1962
Mr. Robb A. LeMasters Sr. VP & CFO 1978
Mr. Thomas E. McCabe Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. 1955
Mr. Richard W. Loving Special Advisor 1956
Mr. Robert L. Duffy Sr. VP & Chief Admin. Officer 1967
Mr. Mark A. Kratz VP of Investor Relations NA
Mr. John R. MacQuarrie Pres of Commercial Operations Segment NA
Ms. Heatherly H. Dukes Pres of BWXT Technical Services Group Inc NA
Ms. Suzanne C. Sterner Sr. VP & Chief Corp. Affairs Officer NA
Dr. Jonathan W. Cirtain Ph.D. Sr. VP, Chief Devel. Officer and Pres & CEO of BWXT Medical Ltd NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.